A detailed history of Wells Fargo & Company transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 2,650 shares of GANX stock, worth $5,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,650
Previous 3,756 29.45%
Holding current value
$5,777
Previous $14,000 78.57%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.24 - $3.99 $1,371 - $4,412
-1,106 Reduced 29.45%
2,650 $3,000
Q1 2024

May 10, 2024

BUY
$3.21 - $5.04 $93 - $146
29 Added 0.78%
3,756 $14,000
Q4 2023

Feb 09, 2024

BUY
$2.07 - $3.4 $8 - $13
4 Added 0.11%
3,727 $12,000
Q3 2023

Nov 13, 2023

BUY
$3.19 - $4.68 $15 - $23
5 Added 0.13%
3,723 $12,000
Q2 2023

Aug 15, 2023

BUY
$4.36 - $5.5 $21 - $27
5 Added 0.13%
3,718 $16,000
Q1 2023

May 12, 2023

BUY
$3.18 - $5.16 $3 - $5
1 Added 0.03%
3,713 $17,000
Q4 2022

Feb 13, 2023

BUY
$2.89 - $3.35 $2,892 - $3,353
1,001 Added 36.92%
3,712 $11,000
Q3 2022

Nov 14, 2022

BUY
$3.17 - $4.21 $114 - $151
36 Added 1.35%
2,711 $9,000
Q2 2022

Aug 12, 2022

BUY
$2.56 - $4.56 $5 - $9
2 Added 0.07%
2,675 $10,000
Q1 2022

May 16, 2022

BUY
$3.15 - $5.59 $8,347 - $14,813
2,650 Added 11521.74%
2,673 $11,000
Q3 2021

Nov 15, 2021

SELL
$7.01 - $10.26 $7 - $10
-1 Reduced 4.17%
23 $0
Q2 2021

Aug 16, 2021

BUY
$8.96 - $15.8 $215 - $379
24 New
24 $0

Others Institutions Holding GANX

About Gain Therapeutics, Inc.


  • Ticker GANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,883,400
  • Market Cap $25.9M
  • Description
  • Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...
More about GANX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.